[an error occurred while processing this directive] | ����Ƥ���Բ�ѧ��־ 2003, 29(6) 364-366 DOI: ISSN: 2096-5540 CN: 32-1880/R | ||||||||||||||||||||||||||||||||||||||||||||||||||
����Ŀ¼ | ����Ŀ¼ | ������� | ������ [��ӡ��ҳ] [�ر�] | |||||||||||||||||||||||||||||||||||||||||||||||||||
���� |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
һ��������һ��������ø��Ƥ��Ѫ�����Լ��� | |||||||||||||||||||||||||||||||||||||||||||||||||||
��, �����, ¬��÷ | |||||||||||||||||||||||||||||||||||||||||||||||||||
ɽ��ʡƤ�����Բ������о���, ���� 250022 | |||||||||||||||||||||||||||||||||||||||||||||||||||
ժҪ��
һ��������������Ҫ���ź�ת������,���й㷺������ѧЧӦ.һ��������ø�ı�������߷��ӵĵ���.����о�����,һ��������һ��������ø����쳣��Ƥ��Ѫ�����Լ����ķ�����ϵ����.�־�һ��������һ��������ø������Ƥ��Ѫ�����Լ����Ĺ�ϵ���о���״��������. | |||||||||||||||||||||||||||||||||||||||||||||||||||
�ؼ����� һ������ һ��������ø Ƥ������,Ѫ���� | |||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract: | |||||||||||||||||||||||||||||||||||||||||||||||||||
Keywords: | |||||||||||||||||||||||||||||||||||||||||||||||||||
�ո����� 2002-12-24 ������ ����淢������ | |||||||||||||||||||||||||||||||||||||||||||||||||||
DOI: | |||||||||||||||||||||||||||||||||||||||||||||||||||
������Ŀ: | |||||||||||||||||||||||||||||||||||||||||||||||||||
ͨѶ����: | |||||||||||||||||||||||||||||||||||||||||||||||||||
�����: | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
�ο����ף� | |||||||||||||||||||||||||||||||||||||||||||||||||||
[1] Lucas KA,Pitari GM,Kazerounian S,et al.Guanylyl cyclases and signaling by cyclic GMP.Pharmacol Rev,2000,52(3):375-414. [2] Moncada S,Palmer RM,Higgs EA.Nitric oxide:physiology,pathophysiology,and pharmacology.Pharmacol Rev,1991,43(2):109-142. [3] Abramson SB,Amin AR,Clancy RM,et al.The role of nitric oxide in tissue destruction.Best Pract Res Clin Rheumatol,2001,15(5):831-845. [4] Mullet D,Fertel RH,Kniss D,et al.An increase in intracellular cyclic AMP modulates nitric oxide production in IFN-gamma-treatedmacrophages.J Immunol,1997,158(2):897-904. [5] Erwig LP,Kluth DC,Walsh GM,et al.Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines.J Immunol,1998,161(4):1983-1988. [6] Benbernou N,Esnanlt S,Shin HC,et al.Differential regulation of IFN-gamma,IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway.Immunology,1997,91(3):361-368. [7] Bingisser RM,Tilbrook PA,Holt PG,et al.Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway.J Immunol,1998,160(12):5729-5734. [8] Chung HT,Pae HO,Choi BM,et al.Nitric oxide as a bioregulator of apoptosis.Biochem Biophys Res Commun,2001,282(5):1075-1079. [9] Kolb JP.Pro-and anti-apoptotic role of nitric oxide,NO.C R AcadSci ��,2001,324(5):413-424. [10] Pozza M,Guerra M,Manzini E,et al.A histochemical study of the rheumatoid synovium:focus on nitric oxide,nerve growth factor high affinity receptor,and innervation.J Rheumatol,2000,27(5):1121-1127. [11] Martinez-Mier G,Toledo-Pereyra LH,Bussell S,et al.Nitric oxide diminishes apoptosis and p53 gene expression after renal ischemia and reperfusion injury.Transplantation,2000,70(10):1431-1437. [12] Yang F,yon Knethen A,Brune B.Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1).J Leukoc Biol,2000,68(6):916-922. [13] Whittle BJ,Morschl E,Pozsar J,et al.Helicobacter pylori lipopolysaccharide provokes iNOS-mediated acute systemic microvascular inflammatory responses in rat cardiac,hepatic,renal and pulmonary tissues.J Physiol Paris,2001,95(1-6):257-259. [14] Weinberg JB.Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.Environ Health Perspect,1998,106(Suppl 5:1131-1137. [15] Satoi H,Oka N,Kawasaki T,et al.Mechanisms of tissue injury in vasculitic neuropathies.Neurology,1998,50(2):492-496. [16] Banno S,Tamada Y,Matsumoto Y,et al.Apoptotic cell death ofneutrophils in development of skin lesions of patients with anaphylactoid purpura.J Dermatol,1997,24(2):94-99. [17] Evereklioglu C,Turkoz Y,Er H,et al.Increased nitric oxide production in patients with Behcet's disease:is it a new activity marker? J Am Acad Dermatol,2002,46(1):50-54. [18] Yilmaz G,Sizmaz S,Yilmaz ED,et al.Aqueous humor nitric oxide levels in patients with Behcet disease.Retina,2002,22(3):330-335. [19] Salvarani C,Boiardi L,Casali B,et al.Endothelial nitric oxide synthase gene polymorphisms in Behcet's disease.J Rheumatol,2002,29(3):535-540. [20] Er H,Evereklioglu C,Cumurcu T,et al.Serum homocysteine level is increased and correlated with endothelin-1 and nitric oxide in Behcet's disease.Br J Ophthalmol,2002,86(6):653-657. [21] Kiraz S,Ertenli I,Calguneri M,et al.Interactions of nitric oxide and superoxide dismutase in Behcet's disease.Clin Exp Rheumatol,2001,19(5 Suppl 24):S25-S29. [22] Heeringa P,Bijl M,de Jager-Krikken A,et al.Renal expression of endothelial and inducible nitric oxide synthase,and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener'sgranulomatosis.J Pathol,2001,193(2):224-232. [23] Haubitz M,Busch T,Gerlach M,et al.Exhaled nitric oxide in patients with Wegener's granulomatosis.Eur Respir J,1999,14(1):113-117. [24] Gilkeson G,Cannon C,Oates J,et al.Correlation of serum measures of nitric oxide production with lupus disease activity.J Rheumatol,1999,26(2):318-324. [25] Leone AM,Francis PL,Rhodes P,et al.A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis.Biochem Biophys Res Commun,1994,200(2):951-957. [26] Svenungsson E,Andersson M,Brundin L,et al.Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus.Ann Rheum Dis,2001,60(4):372-379. [27] Borkowski A,Younge BR,Szweda L,et al.Reactive nitrogen intermediates in giant cell arteritis:selective nitration of neocapillaries.Am J Pathol,2002,161(1):115-123. |
|||||||||||||||||||||||||||||||||||||||||||||||||||
������������� | |||||||||||||||||||||||||||||||||||||||||||||||||||
1������������, ֣������У.һ��������Ƥ��[J]. ����Ƥ���Բ�ѧ��־, 1998,24(6): 325-328 | |||||||||||||||||||||||||||||||||||||||||||||||||||
2�����������, ֣������У.һ����������֢�����ߵ����е�����[J]. ����Ƥ���Բ�ѧ��־, 1999,25(4): 233-235 | |||||||||||||||||||||||||||||||||||||||||||||||||||
3������, ��ǿ, ��¡��.һ�����������ϸ��[J]. ����Ƥ���Բ�ѧ��־, 2002,28(4): 237-239 | |||||||||||||||||||||||||||||||||||||||||||||||||||
4��������, ֣ï��, ����Դ.һ�������������γ�ϸ������м��[J]. ����Ƥ���Բ�ѧ��־, 2003,29(1): 17-19 | |||||||||||||||||||||||||||||||||||||||||||||||||||
5��̷ѩ��, Ϳ��ϼ, ����Ȼ.������һ�����������������[J]. ����Ƥ���Բ�ѧ��־, 2003,29(3): 158-160 | |||||||||||||||||||||||||||||||||||||||||||||||||||
6���վ�, Ϳ��ͥ.һ��������һ��������ø����Ժ�����[J]. ����Ƥ���Բ�ѧ��־, 2004,30(1): 44-47 | |||||||||||||||||||||||||||||||||||||||||||||||||||
7�����Ѳ�, ���.����Ѫ�ܻ�����������м��[J]. ����Ƥ���Բ�ѧ��־, 2005,31(2): 99-101 | |||||||||||||||||||||||||||||||||||||||||||||||||||
�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���ص�����!�������ݲ�����վ�۵�.) | |||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright 2008 by ����Ƥ���Բ�ѧ��־ |